BidaskClub downgraded shares of iKang Healthcare Group (NASDAQ:KANG) from a sell rating to a strong sell rating in a report published on Wednesday morning.
Separately, TheStreet downgraded shares of iKang Healthcare Group from a c rating to a d+ rating in a research note on Wednesday, August 15th.
iKang Healthcare Group stock opened at $15.90 on Wednesday. The company has a market capitalization of $1.19 billion, a PE ratio of 59.21 and a beta of 0.12. iKang Healthcare Group has a 1 year low of $14.21 and a 1 year high of $21.01. The company has a current ratio of 0.71, a quick ratio of 0.69 and a debt-to-equity ratio of 0.08.
iKang Healthcare Group (NASDAQ:KANG) last released its quarterly earnings results on Thursday, September 27th. The medical research company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $150.24 million for the quarter. iKang Healthcare Group had a negative net margin of 2.44% and a positive return on equity of 5.22%.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Northern Trust Corp increased its stake in iKang Healthcare Group by 5.6% during the 1st quarter. Northern Trust Corp now owns 58,780 shares of the medical research company’s stock worth $1,174,000 after buying an additional 3,112 shares during the period. JPMorgan Chase & Co. purchased a new stake in iKang Healthcare Group during the 1st quarter worth approximately $147,000. Tower Research Capital LLC TRC purchased a new stake in iKang Healthcare Group during the 2nd quarter worth approximately $198,000. Jane Street Group LLC purchased a new stake in iKang Healthcare Group during the 2nd quarter worth approximately $226,000. Finally, Aperio Group LLC purchased a new stake in iKang Healthcare Group during the 2nd quarter worth approximately $237,000. 52.13% of the stock is currently owned by hedge funds and other institutional investors.
About iKang Healthcare Group
iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items.
Recommended Story: What is a Tariff?
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.